China Cataract Surgery Devices Market Overview,2030

China’s cataract surgery devices market has undergone a remarkable transformation over the years, growing from a small-scale medical segment into one of the most advanced and competitive markets in Asia. Historically, cataract treatment in China was limited to basic manual extracapsular surgeries, with restricted access to advanced ophthalmic technologies. However, with rapid healthcare modernization, the introduction of phacoemulsification systems, and the availability of intraocular lenses (IOLs), China entered a new era of precision-based cataract surgery. Over the last two decades, the government has heavily invested in improving ophthalmic infrastructure through public hospital upgrades, training programs for surgeons, and the inclusion of cataract surgeries in public healthcare insurance. The demand for cataract surgery devices in China continues to rise due to the growing elderly population, increased awareness of eye health, and expanding access to healthcare in rural regions. With more than 250 million people aged 60 and above, China faces a surging prevalence of cataract cases, driving hospitals and clinics to invest in modern phacoemulsification devices, advanced viscoelastic agents, and premium IOLs that provide better visual outcomes. China’s National Medical Products Administration (NMPA) plays a central role in overseeing the certification, safety, and efficacy of cataract surgery devices. Every device, whether imported or locally manufactured, must undergo rigorous testing, clinical evaluation, and quality certification before market entry. The regulatory environment has become stricter to ensure the highest standards of medical safety, with new frameworks encouraging transparency, traceability, and post-market surveillance.

According to the research report ""China Cataract Surgery Devices Market Overview, 2030,"" published by Bonafide Research, the China Cataract Surgery Devices market is anticipated to grow at 5.19% CAGR from 2025 to 2030. Promotional and marketing strategies in the Chinese cataract surgery device sector focus primarily on professional engagement, training, and awareness rather than direct-to-consumer advertising. Manufacturers invest heavily in organizing surgical workshops, ophthalmic conferences, and partnerships with hospitals to demonstrate the benefits of advanced devices. Educational campaigns aimed at rural populations emphasize the safety and accessibility of modern cataract procedures, helping to reduce fear and increase patient turnout. Meanwhile, digital platforms are being increasingly utilized for product education and professional networking, helping companies build brand trust in a regulated environment. The Chinese government’s commitment to improving healthcare accessibility through national programs such as “Vision 2020” and rural cataract treatment initiatives has further accelerated the adoption of modern cataract surgery techniques across the country. Public hospitals and private eye clinics are now equipped with advanced phacoemulsification systems and foldable intraocular lenses (IOLs), enabling quicker, safer, and more effective surgeries that significantly reduce recovery time. Technological innovation is another critical growth driver. The market has seen the emergence of smart, AI-integrated cataract surgery devices, digital imaging systems, and advanced IOLs that provide superior visual clarity and minimize post-surgery complications. Domestic manufacturers have started to compete with international brands by developing high-quality and cost-effective devices that meet international standards, helping China move toward self-reliance in the medical device sector.

Intra-ocular lenses (IOLs) dominate the market, as cataract surgery is among the most frequently performed ophthalmic procedures in the country. The demand for IOLs continues to rise sharply, supported by government-led programs such as the National Cataract Surgery Program, which focuses on eliminating cataract-related blindness and improving access to surgical care. Public hospitals typically use monofocal IOLs for state-funded procedures, ensuring affordability and wide accessibility. In contrast, private hospitals and urban specialty eye centers increasingly offer premium IOLs including toric, multifocal, and extended-depth-of-focus designs catering to patients who are willing to pay for enhanced vision quality and reduced dependence on glasses. Local manufacturing of IOLs has expanded significantly in China, with domestic companies offering cost-effective alternatives and competing strongly with global brands. Phacoemulsification systems represent another vital component of the market, as the transition from traditional extracapsular extraction to modern phaco-based procedures accelerates. Chinese hospitals, both public and private, are rapidly adopting advanced phaco machines for their efficiency, smaller incisions, and faster patient recovery times. Ophthalmic viscoelastic devices (OVDs) have also seen growing consumption as surgical volumes rise, as they are indispensable in every cataract surgery to protect ocular tissues and facilitate smooth lens implantation. The femtosecond laser systems segment, though relatively small, is steadily growing among high-end private hospitals and teaching institutions in major cities such as Beijing, Shanghai, and Guangzhou. These systems are promoted for their precision and safety benefits, appealing to affluent patients seeking technologically advanced cataract procedures.

Public hospitals are responsible for implementing large-scale cataract surgery programs aimed at reducing blindness, and they rely on standardized and cost-effective surgical devices, including locally produced IOLs and phacoemulsification systems. Government investment in healthcare infrastructure, particularly through the “Healthy China 2030” initiative, has resulted in the modernization of ophthalmology departments across provincial and county-level hospitals, improving access to advanced surgical technologies. Alongside this, private hospitals and specialized ophthalmic chains have expanded rapidly, offering high-quality and premium cataract surgery options to urban and higher-income patients. Leading eye hospital networks such as Aier Eye Hospital and Bright Eye Hospital Group have played a major role in upgrading surgical standards and increasing adoption of premium IOLs and femtosecond laser systems. Ambulatory surgery centers (ASCs) are emerging in larger cities, encouraged by regulatory reforms that promote outpatient care to ease the burden on hospitals and improve patient convenience. These centers focus on efficiency, reduced waiting times, and patient-centered service models, often equipped with advanced phaco platforms and a wide range of consumables. Ophthalmology clinics across urban and semi-urban areas contribute by providing diagnostics, consultations, and follow-up care, while referring patients to hospitals or surgical centers for procedures. Academic and research institutes, including those affiliated with top medical universities, play a key role in training surgeons, conducting device trials, and developing innovative technologies, such as domestically produced premium IOLs and surgical instruments.

Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030

Aspects covered in this report
• Cataract Surgery Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Intra-ocular Lenses (IOL)
• Phacoemulsification Systems
• Ophthalmic Viscoelastic Devices
• Femtosecond Laser Systems
• Others (Knives and Low-Cost Consumables)

By End User
• Hospitals
• Ambulatory Surgery Centers
• Ophthalmology Clinics
• Academic and Research Institutes Show more